UNIXELL
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
UNIXELL
Industry:
Biotechnology Medical
Founded:
2021-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
200 M CNY
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
CuResponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
KayoThera
KayoThera develops therapeutics used to cure late-stage and metastatic cancers.
Mercator MedSystems
Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.
Promedigen
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.
SonALAsense
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
Investors List
Fosun Pharma
Fosun Pharma investment in Seed Round - UniXell
GL Ventures LLC
GL Ventures LLC investment in Seed Round - UniXell
Kunlun Capital
Kunlun Capital investment in Seed Round - UniXell
Sherpa Healthcare Partners
Sherpa Healthcare Partners investment in Seed Round - UniXell
Winfast Holding
Winfast Holding investment in Seed Round - UniXell
TF Capital
TF Capital investment in Seed Round - UniXell
CDH Investments
CDH Investments investment in Seed Round - UniXell
Kunlun Capital
Kunlun Capital investment in Angel Round - UniXell
GL Ventures LLC
GL Ventures LLC investment in Angel Round - UniXell
More informations about "UniXell"
上海跃赛生物科技有限公司 - unixell.com
UniXell is an innovative biotechnology company specialized in developing hPSC based cell therapy products. Since its founding in 2021, Unixell has developed multiple key technology platforms, including Reprogramming technology, …See details»
UniXell - Crunchbase Company Profile & Funding
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.See details»
UniXell Biotechnology 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for UniXell Biotechnology. Use the PitchBook Platform to explore the full profile.See details»
Unixell Advances in Cell Therapy with CDE IND …
Oct 6, 2024 Unixell has a solid foundation in cell therapy technology research, particularly achieving a world-class level in the research and development of neural system cell therapies, with multiple patents to its name.See details»
UniXell Biotech launches GMP production base - Pudong
Apr 12, 2023 On April 8, Shanghai UniXell Biotechnology's production base at Good Manufacturing Practice level was officially put into operation in No.1 Life Science and …See details»
UniXell DA-001 - Drug Targets, Indications, Patents - Synapse
UniXell DA-001, Initially developed by Shanghai Yusai Biotechnology Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System …See details»
上海跃赛生物科技有限公司 - unixell.com
These technological advantages enable UniXell to manufacture cell products of high purity and batch consistency, advancing toward the ultimate clinical goals of efficiency and safety. …See details»
UniXell - Golden
UniXell is a Shanghai-based company.Find more companies like UniXell Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the …See details»
UniXell - Crunchbase
UniXell, HebeCell, Mercator MedSystems, Edison Pharmaceuticals, Gracell Biotechnologies, and KayoThera are all involved in the biotechnology and pharmaceutical sector. HebeCell, …See details»
What is UniXell Biotechnology? Company Culture, Mission, Values
See what employees say it's like to work at UniXell Biotechnology. Salaries, reviews, and more - all posted by employees working at UniXell Biotechnology.See details»
Shanghai Yusai Biotechnology Co., Ltd. (上海毓赛生物科技有限公 …
了解Shanghai Yusai Biotechnology Co., Ltd. (上海毓赛生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:内分泌与代谢疾病，神经系统疾病，技术平台:干细胞 …See details»
UniXell Biotechnology - Crunchbase Company Profile & Funding
UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.See details»
上海跃赛生物科技有限公司
万户网络ezEIP5.0About Us About UniXell Vision History Manufacturing Base About UniXell UniXell Biotechnology, a leading company in the field of human PSC derived cell therapy for …See details»
unixell.com - 上海跃赛生物科技有限公司
Oct 14, 2024 跃赛生物是一家专注于开发新一代基于人多能干细胞的细胞治疗药物的创新型制药公司。 自2021年创立以来，团队开发了重编程技术平台、干细胞分化平台、SISBAR谱系示踪 …See details»
UniXell - Funding, Financials, Valuation & Investors - Crunchbase
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.See details»
跃赛生物（UniXell）完成数千万元A+轮融资 - 创投之家
Jul 12, 2024 致力于开发多能干细胞药物的企业——上海跃赛生物科技有限公司（跃赛生物，UniXell）继今年4月完成A轮超亿元融资后，再次完成数千万A+轮融资。本轮融资由国科创 …See details»
Series A - UniXell Biotechnology - 2024-04-02 - Crunchbase
Apr 2, 2024 UniXell Biotechnology raised $13824757 on 2024-04-02 in Series ASee details»
上海跃赛生物科技有限公司 - unixell.com
上海跃赛生物科技有限公司，全球人多能干细胞来源神经系统疾病细胞疗法的领军企业，成立于2021年，在上海市自由贸易试验区自贸壹号生命科技产业园二期建有总面积约4000平米的研 …See details»
UniXell Biotechnology - Funding, Financials, Valuation & Investors
UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.See details»
UniXell - Tech Stack, Apps, Patents & Trademarks - Crunchbase
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.See details»